Kalaris Therapeutics (KLRS) Stock Chart & Stock Price History $2.69 +0.01 (+0.37%) As of 08/1/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsSEC FilingsTrendsBuy This Stock Kalaris Therapeutics Stock Price Performance The Kalaris Therapeutics (KLRS) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 5.08%, reflecting recent market activity. As of the latest close, Kalaris Therapeutics traded at $2.69 with a market cap of $50.31 million and volume of 52,807 shares. Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-7.88%1 Month Performance+5.08% KLRS Stock Chart for Saturday, August, 2, 2025 KLRS Chart by TradingView Kalaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$2.68$2.69+0.37%$2.75$2.5652,807 shs$50.31 million07/31/2025$2.69$2.68-0.37%$2.96$2.6219,055 shs$50.12 million07/30/2025$2.69$2.69$2.82$2.6915,174 shs$50.30 million07/29/2025$2.92$2.69-7.88%$2.97$2.6572,827 shs$50.31 million07/28/2025$2.76$2.92+5.80%$2.97$2.7832,006 shs$54.60 million07/25/2025$2.84$2.76-2.82%$2.96$2.6641,291 shs$51.61 million07/24/2025$2.77$2.84+2.53%$2.96$2.7837,505 shs$53.11 million07/23/2025$2.57$2.77+7.78%$2.97$2.53132,939 shs$51.81 million07/22/2025$2.42$2.57+6.20%$2.59$2.41148,218 shs$48.06 million07/21/2025$2.39$2.42+1.26%$2.50$2.3923,351 shs$45.25 million Get the Latest News and Ratings for KLRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$2.42$2.39-1.24%$2.54$2.3740,606 shs$44.69 million07/17/2025$2.46$2.42-1.63%$2.52$2.35203,569 shs$45.26 million07/16/2025$2.40$2.46+2.50%$2.59$2.4036,951 shs$46.00 million07/15/2025$2.61$2.40-8.05%$2.60$2.3363,337 shs$44.88 million07/14/2025$2.43$2.61+7.41%$2.62$2.4633,885 shs$48.81 million07/11/2025$2.50$2.43-2.80%$2.65$2.4268,547 shs$45.44 million07/10/2025$2.55$2.50-1.96%$2.64$2.4024,661 shs$46.76 million07/09/2025$2.58$2.55-1.16%$2.64$2.3665,206 shs$47.69 million07/08/2025$2.61$2.58-1.15%$2.64$2.5511,765 shs$48.25 million07/07/2025$2.50$2.61+4.40%$2.61$2.4014,600 shs$48.81 million07/04/2025$2.50$2.50$2.69$2.5035,701 shs$46.75 million07/03/2025$2.56$2.50-2.34%$2.69$2.5035,701 shs$46.76 million07/02/2025$2.58$2.56-0.78%$2.75$2.5615,106 shs$47.87 million07/01/2025$2.67$2.58-3.37%$2.73$2.572,793 shs$48.25 million Related Companies OGI Stock Chart EPRX Stock Chart TVGN Stock Chart CTMX Stock Chart ENGN Stock Chart CYBN Stock Chart KYTX Stock Chart IPHA Stock Chart SXTC Stock Chart GALT Stock Chart Receive KLRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Kalaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KLRS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersI warned you about Nvidia… now look what’s happeningNvidia just got Trump’s greenlight to sell high-powered AI chips to China — and their stock surged 5% before t...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kalaris Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kalaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
